OpSens Inc. is a Canadian medical technology firm that specializes in physiological measurements for interventional cardiology. The company focuses on optical-based pressure guidewires to enhance the clinical outcomes of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation guidewire that offers the lowest drift in the industry and provides excellent lesion access. The OptoWire has been used in over 90,000 patients across more than 30 countries and is approved for sale in the United States, European Union, Japan, and Canada. OpSens is committed to ongoing innovation and research to further advance the field of interventional cardiology.